GlassScriptPhysician profile
Timothy L Jackson
NPI 1982623625
$11,587.48
in general payments reported to CMS, 2019-2025
31 companies · $2,328 in 2025
The $2,328 reported for 2025 was more than what 94% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,190 · 2022: $2,294 · 2023: $2,133 · 2024: $2,643 · 2025: $2,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,810 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,809.90 |
| Education | $294.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,499.30 | 2021-2025 | |
| Janssen Biotech, INC. | $1,215.97 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Genzyme Corporation | $938.67 | 2021-2025 | |
| Leo Pharma INC. | $761.71 | 2021-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $637.78 | 2021-2025 | Dupixent |
| Arcutis Biotherapeutics, INC. | $604.05 | 2023-2025 | Zoryve |
| Amgen INC. | $542.05 | 2021-2025 | Otezla, Enbrel, Otezla |
| E.R. Squibb & Sons, L.L.C. | $500.15 | 2022-2025 | Sotyktu |
| Pfizer INC. | $446.43 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $443.28 | 2021-2024 | |
| Lilly USA, LLC | $399.76 | 2021-2025 | Taltz, Ebglyss |
| Novartis Pharmaceuticals Corporation | $293.00 | 2021-2025 | |
| Incyte Corporation | $250.10 | 2021-2025 | Opzelura |
| Galderma Laboratories, L.P. | $239.81 | 2021-2025 | Nemluvio, Epsolay |
| Dermavant Sciences, INC. | $130.29 | 2022-2024 | Vtama |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $127.78 | 2022 | |
| Ucb, INC. | $115.85 | 2021-2023 | Cimzia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.43 | 2023-2024 | Cyltezo, Spevigo |
| Sanofi-Aventis U.S. LLC | $99.00 | 2021 | |
| Vyne Pharmaceuticals INC. | $70.63 | 2021 | |
| Springworks Therapeutics, INC. | $27.95 | 2025 | Gomekli |
| Journey Medical Corporation | $22.14 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $19.80 | 2022 | |
| Almirall LLC | $19.17 | 2021 | |
| Verrica Pharmaceuticals INC. | $17.03 | 2023 | Ycanth |
| Tactile Systems Technology INC | $15.31 | 2023 | Flexitouch Plus, Entre Plus |
| Genentech USA, INC. | $15.23 | 2021 | |
| Fresenius Kabi USA, LLC | $14.58 | 2024 | Idacio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $11.90 | 2021 | |
| Organon LLC | $6.87 | 2025 | Vtama |
| Biofrontera INC. | $1.46 | 2023 | Xepi, Bf-Rhodoled, Ameluz |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.